glp 1 drugs names types of GLP-1 Receptor Agonists: An Alternative for Rapid-Acting Insulin? List of approved and pending

The clinically most relevant and important action of DPP-4 inhibitors is the endogenous elevation of the incretin hormone concentration of GLP-1 that consecutively leads to a glucose-dependent stimulation of insulin secretion and an inhibition of glucagon secretion (10)

The DPP-4 inhibitors, which are oral antidiabetic drugs of a specific class, have now become one of the main therapeutic categories for T2D

[Real-world data come from patients not in clinical trials

95% confidence interval [CI], 3.69 to 2.30) [32]

Further translational research and prospective clinical trials are required to clarify causality, determine effect size, and identify high-risk groups most likely to benefit

Susanne Clara Bard, UC San Diego Beyond the widespread attention GLP-1 drugs are receiving for treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease, emerging research is investigating their other potential impacts including their effects on aging